Structural Basis for Highly Selective Class II Alpha Phosphoinositide-3-Kinase Inhibition

被引:0
|
作者
Kuecuekdisli, Murat [1 ]
Bel-Abed, Hassen [1 ]
Cirillo, Davide [1 ]
Lo, Wen-Ting [1 ]
Efrem, Nina-Louisa [1 ]
Horatscheck, Andre [1 ]
Perepelittchenko, Liudmila [1 ]
Prokofeva, Polina [2 ]
Ehret, Theresa A. L. [3 ,4 ]
Radetzki, Silke [1 ]
Neuenschwander, Martin [1 ]
Specker, Edgar [1 ]
Medard, Guillaume [2 ]
Mueller, Susanne [3 ,4 ]
Wilhelm, Stephanie [2 ]
Kuster, Bernhard [2 ]
von Kries, Jens Peter [1 ]
Haucke, Volker [1 ]
Nazare, Marc [1 ]
机构
[1] Leibniz Forschungsinst Mol Pharmakol FMP, Campus Berlin Buch, D-13125 Berlin, Germany
[2] Tech Univ Munich, Chair Prote & Bioanalyt, D-85354 Freising Weihenstephan, Germany
[3] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany
[4] Struct Genom Consortium SGC, Buchmann Inst Mol Life Sci, D-60438 Frankfurt, Germany
关键词
IMPAIRS PROLIFERATION; ACUTE-LEUKEMIA; BRAIN-TUMORS; 3-KINASE; PI3K; PI3K-C2-ALPHA; MIGRATION; SURVIVAL; PATHWAY;
D O I
10.1021/acs.jmedchem.3c01319
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Class II phosphoinositide-3-kinases (PI3Ks) play central roles in cell signaling, division, migration, and survival. Despite evidence that all PI3K class II isoforms serve unique cellular functions, the lack of isoform-selective inhibitors severely hampers the systematic investigation of their potential relevance as pharmacological targets. Here, we report the structural evaluation and molecular determinants for selective PI3K-C2 alpha inhibition by a structure-activity relationship study based on a pteridinone scaffold, leading to the discovery of selective PI3K-C2 alpha inhibitors called PITCOINs. Cocrystal structures and docking experiments supported the rationalization of the structural determinants essential for inhibitor activity and high selectivity. Profiling of PITCOINs in a panel of more than 118 diverse kinases showed no off-target kinase inhibition. Notably, by addressing a selectivity pocket, PITCOIN4 showed nanomolar inhibition of PI3K-C2 alpha and >100-fold selectivity in a general kinase panel. Our study paves the way for the development of novel therapies for diseases related to PI3K-C2 alpha function.
引用
收藏
页码:14278 / 14302
页数:25
相关论文
共 50 条
  • [21] Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase Inhibitors
    Burger, Matthew T.
    Knapp, Mark
    Wagman, Allan
    Ni, Zhi-Jie
    Hendrickson, Thomas
    Atallah, Gordana
    Zhang, Yanchen
    Frazier, Kelly
    Verhagen, Joelle
    Pfister, Keith
    Ng, Simon
    Smith, Aaron
    Bartulis, Sarah
    Merrit, Hanne
    Weismann, Marion
    Xin, Xiaohua
    Haznedar, Joshua
    Voliva, Charles F.
    Iwanowicz, Ed
    Pecchi, Sabina
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (01): : 34 - 38
  • [22] Phosphoinositide-3-kinase regulation of neutrophil mechanosensing is context dependent
    O'Brien, Xian
    Oakley, Katie E.
    Loosley, Alex J.
    Tang, Jay X.
    Reichner, Jonathan S.
    FASEB JOURNAL, 2013, 27
  • [23] Class II phosphoinositide 3-kinase in insulin resistance
    Falasca, M.
    Hughes, W. E.
    James, D. E.
    Shepherd, P. R.
    Dominguez, V.
    Maffucci, T.
    DIABETIC MEDICINE, 2008, 25
  • [24] Structural insights into the origin of phosphoinositide 3-kinase inhibition
    Safoura Hariri
    Behnam Rasti
    Mirsasan Mirpour
    Gholamreza Vaghar-Lahijani
    Farnoosh Attar
    Fereshteh Shiri
    Structural Chemistry, 2020, 31 : 1505 - 1522
  • [25] Structural insights into the origin of phosphoinositide 3-kinase inhibition
    Hariri, Safoura
    Rasti, Behnam
    Mirpour, Mirsasan
    Vaghar-Lahijani, Gholamreza
    Attar, Farnoosh
    Shiri, Fereshteh
    STRUCTURAL CHEMISTRY, 2020, 31 (04) : 1505 - 1522
  • [26] Biological characterization of ETP-46321 a potent and selective phosphoinositide-3-kinase inhibitor with antitumor activity
    Bischoff, J. R.
    Pastor, J.
    Cebrian, D.
    Martinez, S.
    Lorenzo, M.
    Merino, T.
    Fominaya, J.
    Pizcueta, P.
    Rodriguez Lopez, A.
    Granda, T. G.
    EJC SUPPLEMENTS, 2010, 8 (07): : 49 - 49
  • [27] Synergistic induction of cell death in haematological malignancies by combined phosphoinositide-3-kinase and BET bromodomain inhibition
    Tinsley, Steven
    Meja, Koremu
    Shepherd, Clare
    Khwaja, Asim
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (02) : 275 - 278
  • [28] Structural basis for the highly selective inhibition of MMP-13
    Engel, CK
    Pirard, B
    Schimanski, S
    Kirsch, R
    Habermann, J
    Klingler, O
    Schlotte, V
    Weithmann, KU
    Wendt, KU
    CHEMISTRY & BIOLOGY, 2005, 12 (02): : 181 - 189
  • [29] Phosphoinositide-3-kinase signaling and the control of sperm motility in the porcine oviduct
    Satake, N.
    Watson, P. F.
    Holt, W. V.
    REPRODUCTION FERTILITY AND DEVELOPMENT, 2008, 20 (01) : 193 - 193
  • [30] Phosphoinositide-3-Kinase Dependent Signaling in Mammalian Olfactory Receptor Neurons
    Ukhanov, Kirill
    Corey, Elizabeth A.
    Klasen, Katharina
    Brunert, Daniela
    Ache, Barry W.
    CHEMICAL SENSES, 2009, 34 (07) : A74 - A74